Company Analysis

Akari Therapeutics plc (AKTX)

Nasdaq: AKTX · Pharmaceutical Preparations · Tampa, FL · filing with the SEC since 2012
Grade3.5
◀ Past 3.4● Present 3.0▶ Future 3.8
6 est.

Filings

448 filings since 2017 beside 87 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by May 15, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 43 days after the quarter ended. The proxy statement was last filed Oct 1, 2026.

Filings a yearinsider forms included
5454413753898559
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 14 times in the last 36 months, the newest Oct 1, 2026.Listing warning from its exchange (8-K item 3.01): 4 times in the last 36 months, the newest Nov 26, 2025.SEC letters: 12 in the last 36 months, the newest Jan 27, 2026.A late-filing notice, Form NT 10-Q, filed May 18, 2026.A late-filing notice, Form NT 10-K, filed Mar 31, 2025.A late-filing notice, Form NT 10-Q, filed Nov 15, 2024.A late-filing notice, Form NT 10-Q, filed Aug 15, 2024.
Insider forms 87

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 12, 2026 8-K items 2.02, 9.01 Results released · Current report
Nov 12, 2026 10-Q Quarterly report Sep 30, 2026
Nov 12, 2026 SCHEDULE 13G/A Large holder update, amended
Oct 30, 2026 S-8 Employee stock plan registration
Oct 30, 2026 8-K items 5.07, 9.01 Shareholder vote · Current report Oct 28, 2026
Oct 1, 2026 DEF 14A Proxy statement
Oct 1, 2026 8-K items 5.02, 9.01 Officer or director change · Current report Sep 29, 2026
Aug 13, 2026 8-K items 2.02, 9.01 Results released · Current report
Aug 13, 2026 10-Q Quarterly report Jun 30, 2026
Aug 12, 2026 SCHEDULE 13G Large holder notice
Aug 7, 2026 SCHEDULE 13G Large holder notice
Jul 13, 2026 EFFECT Registration effective
Jul 10, 2026 S-3/A Shelf registration, amended
Jul 8, 2026 S-3/A Shelf registration, amended
Jul 7, 2026 EFFECT Registration effective
Jul 2, 2026 8-K items 5.07, 9.01 Shareholder vote · Current report Jun 30, 2026
Jul 2, 2026 S-3 Shelf registration
Jun 26, 2026 8-K items 1.01, 9.01 Major agreement signed · Current report Jun 23, 2026
Jun 26, 2026 S-1/A Listing registration, amended
Jun 8, 2026 SCHEDULE 13G Large holder notice
Jun 4, 2026 DEF 14A Proxy statement
Jun 3, 2026 D Private placement notice
May 22, 2026 PRE 14A Preliminary proxy statement
May 22, 2026 8-K items 1.01, 3.02, 9.01 Major agreement signed; Shares sold without registration · Current report May 20, 2026
May 21, 2026 RW Registration withdrawal request
May 19, 2026 10-Q Quarterly report Mar 31, 2026
May 18, 2026 NT 10-Q Late quarterly report notice Mar 31, 2026
May 8, 2026 S-1 Listing registration
Apr 15, 2026 EFFECT Registration effective
Apr 10, 2026 POS AM Registration amended after taking effect
Apr 2, 2026 DRS Draft registration, confidential
Mar 31, 2026 F-6/A Depositary shares registration, amended
Mar 30, 2026 10-K Annual report Dec 31, 2025
Mar 17, 2026 8-K items 3.03, 7.01, 9.01 Change to shareholders' rights; Investor disclosure (Regulation FD) · Current report
Mar 4, 2026 SCHEDULE 13D/A Activist holder update, amended
Mar 4, 2026 SCHEDULE 13D/A Activist holder update, amended
Mar 4, 2026 SCHEDULE 13G/A Large holder update, amended
Mar 2, 2026 8-K item 5.07 Shareholder vote · Current report
Feb 2, 2026 DEF 14A Proxy statement
Jan 29, 2026 EFFECT Registration effective
40 of 448 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton AKTX · research, not advice